Jakob L Hansen

Title: The Innovations of Jakob L Hansen

Introduction

Jakob L Hansen is a notable inventor based in Copenhagen, Denmark. He has made significant contributions to the field of pharmacogenomics, particularly in the area of G-protein coupled receptors (GPCRs). His work focuses on improving drug therapy outcomes through genetic screening.

Latest Patents

Jakob L Hansen holds a patent titled "Clinical indications for genotyping polymorphic variants of G-protein coupled receptors." This invention provides compositions and methods for screening individuals for the presence of GPCR variants. The compositions and methods are useful for determining the clinical outcome of drug therapy or for tailoring drug therapy for individuals based on the presence or absence of one or more GPCR variants in the subject. He has 1 patent to his name.

Career Highlights

Hansen is currently associated with Acadia Pharmaceuticals Inc., where he continues to advance his research and innovations. His work has the potential to significantly impact personalized medicine and drug development.

Collaborations

Throughout his career, Jakob has collaborated with esteemed colleagues such as David M Weiner and Mark R Brann. These partnerships have fostered a collaborative environment that enhances the research and development of innovative solutions in pharmacogenomics.

Conclusion

Jakob L Hansen's contributions to the field of pharmacogenomics exemplify the importance of innovation in medicine. His work on GPCR variants is paving the way for more effective and personalized drug therapies.